Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/08830185.2020.1840566 http://scihub22266oqcxt.onion/10.1080/08830185.2020.1840566 33111578!ä!33111578 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+Rev+Immunol 2021 ; 40 (1-2): 54-71 Nephropedia Template TP {{tp|p=33111578|t=2021. Pathogenesis guided therapeutic management of COVID-19: an immunological perspective |pdf=|usr=}}{{33111578}} gab.com Text Pathogenesis guided therapeutic management of COVID-19: an immunological perspective JO: Int Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33111578 #FOAvip Lack of standardized therapeutic approaches is arguably the significant contributor to the high burden of mortality observed in the ongoing pandemic of the Coronavirus disease, 2019 (COVID-19). Evidence is accumulating on SARS-CoV-2 specific immune cell dysregulation and consequent tissue injury in COVID-19. Currently, no definite drugs or vaccines are available against the disease; however initial results of the ongoing clinical trials have raised some hope. In this article, taking insights from the emerging empirical evidence about host-virus interactions, we deliberate upon plausible pathogenic mechanisms and suitable therapeutic approaches for COVID-19. Twit Text FOAVip Pathogenesis guided therapeutic management of COVID-19: an immunological perspective ????Int Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33111578 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33111578 #FOAvip English Wikipedia <ref>{{Cite pmid|33111578}}</ref> Pathogenesis guided therapeutic management of COVID-19: an immunological perspective #MMPMID33111578 Kumar A; Prasoon P; Sekhawat PS; Pareek V; Faiq MA; Kumari C; Narayan RK; Kulandhasamy M; Kant K Int Rev Immunol 2021[]; 40 (1-2): 54-71 PMID33111578show ga Lack of standardized therapeutic approaches is arguably the significant contributor to the high burden of mortality observed in the ongoing pandemic of the Coronavirus disease, 2019 (COVID-19). Evidence is accumulating on SARS-CoV-2 specific immune cell dysregulation and consequent tissue injury in COVID-19. Currently, no definite drugs or vaccines are available against the disease; however initial results of the ongoing clinical trials have raised some hope. In this article, taking insights from the emerging empirical evidence about host-virus interactions, we deliberate upon plausible pathogenic mechanisms and suitable therapeutic approaches for COVID-19. |Antiviral Agents/therapeutic use[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19/*immunology/*pathology[MESH] |Complement Activation/immunology[MESH] |Cytokine Release Syndrome/blood/immunology/*pathology[MESH] |Host-Pathogen Interactions/immunology[MESH] |Humans[MESH] |Immunity, Innate/*immunology[MESH]Pathogenesis guided therapeutic management of COVID-19: an immunologic(epmc).pdf DeepDyve Pubget Overpricing